PURPOSE Receipt of antineoplastic systemic treatment near end of life (EOL) has been
shown to harm patient and caregiver experience, increase hospitalizations, intensive care …

Importance Many patients with metastatic cancer receive high-cost, low-value care near the
end of life. Identifying patients with a high likelihood of receiving low-value care is an …

Background: End-of-life management is a difficult aspect of cancer care. With the oncology
care model (OCM), we have data to assess both clinical outcomes and total cost of care …

OBJECTIVES: Palliative care has been demonstrated to have positive effects for patients,
families, health care providers, and health systems. Early identification of patients who are …

Background: Poor stakeholder engagement in advance care planning (ACP) poses national
and international challenges, preventing maximisation of its potential benefits …

Background Patients and their families face financial hardship during cancer treatment,
which may intensify at end of life (EOL) due to increased symptoms and care needs. We …

INTRODUCTION—Palliative care is an interdisciplinary medical specialty that focuses on
preventing and relieving suffering and on supporting the best possible quality of life for …

Abstract Context/Objectives The scarce research on factors associated with surrogate
decisional regret overlooks longitudinal, heterogenous decisional-regret experiences and …

Importance Two prominent organizations, the American Society of Clinical Oncology and the
National Quality Forum (NQF), have developed a cancer quality metric aimed at reducing …

Purpose Cancer patients heterogeneously develop prognostic awareness, and end-of-life
cancer care has become increasingly aggressive to the detriment of patients and healthcare …